Avenue Therapeutics Announces FDA Advisory Committee Meeting to Review IV Tramadol NDA Tentatively Scheduled for February 15, 2022
Avenue Therapeutics Announces Exercise and Closing of Underwriter’s Over-Allotment Option
Journey Medical Corporation Announces Closing of Initial Public Offering
Dawson James Securities’ 6th Annual Small Cap Growth Conference
Stay informed and receive company updates straight to your inbox.